TSHA
Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Taysha Gene Therapies Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Taysha Gene Therapies Inc. revenue for the twelve months ending March 31, 2026 was 4.3 M, a 61.22% decrease year-over-year.
- Taysha Gene Therapies Inc. annual revenue for 2025 was 9.8 M, a 17.28% increase from 2024.
- Taysha Gene Therapies Inc. annual revenue for 2024 was 8.3 M, a 46.07% decrease from 2023.
- Taysha Gene Therapies Inc. annual revenue for 2023 was 15.5 M, a 517.55% increase from 2022.
- Taysha Gene Therapies Inc. annual revenue for 2022 was 2.5 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Taysha Gene Therapies Inc. Market Cap — FAQ
Taysha Gene Therapies Inc. (TSHA) market cap over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TSHA's market cap history?
The chart and table above show Taysha Gene Therapies Inc.'s market cap by year and by quarter, including the growth rate.